The Prototype: Study Suggests AI Tools Decrease Critical Thinking Skills
Plus: A startup bioengineering off-the-shelf arteries, how viruses may cause Alzheimer’s, water-powered satellites and more.
The Misconceptions About Anavex Life Sciences' Blarcamesine Phase 2b/3 Trial In Alzheimer's Disease
Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...
Verywell Health on MSN16h
What Happens to Your Brain When You Take These 16 Supplements?
While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...
ORYZON to Provide Corporate Progress Updates at Several Events in January-February
Neuroscience Innovation Forum14th Annual LifeSci Advisors Corporate Access EventInvest Securities BioMed Forum 2025MidCap Events ...
Pharmabiz23h
Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report
Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report: London, UK Friday, January 10, 2025, 14:00 Hrs [IST] Clarivate Plc, a l ...
Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
URMC providing resources for those wanting to quit smoking
January 10 has been named ‘Quitters Day’ because it is the day in which most people have given up on their new year’s ...